$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

BioTelemetry, Inc.
(NASDAQ : BEAT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading BEAT News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
0.35%42.994.9%$434.16m
MDTMedtronic PLC
1.44%86.620.9%$332.37m
STJSt. Jude Medical, Inc.
0.30%78.053.1%$289.59m
ZBHZimmer Biomet Holdings, Inc.
1.07%129.532.4%$184.85m
TMOThermo Fisher Scientific Inc.
0.69%152.401.3%$172.72m
BSXBoston Scientific Corporation
0.86%23.981.2%$171.01m
BAXBaxter International Inc.
0.17%47.183.8%$157.58m
BDXBecton, Dickinson and Company
0.80%175.531.4%$148.53m
EWEdwards Lifesciences Corporation
0.46%115.301.8%$138.43m
ISRGIntuitive Surgical, Inc.
-0.17%685.292.6%$123.04m
SYKStryker Corporation
1.01%114.451.4%$109.26m
HOLXHologic, Inc.
0.96%38.801.5%$95.14m
XRAYDENTSPLY International Inc.
0.95%61.362.6%$90.11m
BCRC. R. Bard, Inc.
0.86%217.161.9%$89.72m
ALGNAlign Technology, Inc.
0.71%92.673.5%$76.32m

Company Profile

BioTelemetry, Inc. cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It also develops proprietary integrated patient management platform that incorporates wireless data transmission network. The company operates through operates through the following segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. BioTelemetry company was founded on April 22, 2013 and is headquartered in Malvern, PA.